TRIUMF acquires ACSI TR-24 cyclotron

ACSI factory

(Richmond, BC) – Advanced Cyclotron Systems, Inc. (ACSI), is pleased to announce that it has signed an agreement for the supply of a TR-24 cyclotron system to be installed at TRIUMF, Canada’s National Laboratory for Particle and Nuclear Physics.

In a ceremony held on May 30th, 2014 at the UBC campus, the Honorable Michelle Rempel, Canadian Minister of State for Western Economic Diversification, announced funding of $5.5 million which will allow TRIUMF to acquire the new cyclotron as well as to develop the Institute for Accelerator-based Medical Isotopes (IAMI). The beam capabilities and energy range of the TR-24 cyclotron make it ideal for production of PET and SPECT isotopes for research and commercial purposes.

The relationship between TRIUMF and ACSI dates back more than 30 years ago, when EBCO (ACSI’s parent company) was contracted to help build TRIUMF’s 500 MeV particle accelerator. That initial relationship gave rise to a technology transfer agreement that subsequently resulted in the commercialization of the TR cyclotrons.

The new TR-24 will be the 4th cyclotron produced by ACSI to be installed on TRIUMF’s Campus. The first one, a TR-30 cyclotron (30 MeV) was acquired by Nordion in 1990.  More than 20 years later, this cyclotron is still in commercial production. A TR-13 cyclotron (13 MeV) was supplied to TRIUMF shortly after in 1993. A third cyclotron, another TR-30 was added in 2003 to increase Nordion’s isotope production capabilities.

In December 2010, TRIUMF and ACSI signed a partnership agreement to advance cyclotron and accelerator technologies and to promote the use of such technologies in providing better healthcare to British Columbians and all Canadians.

The addition of a TR-24 cyclotron to TRIUMF’s cyclotron fleet will enhance its research capabilities, while allowing TRIUMF to continue working towards finding an alternative solution for the shortage of reactor produced medical isotopes. As Paul Schaffer, Head of Nuclear Medicine at TRIUMF explains: “This investment is a crucial step on the road to meeting Canada’s isotope needs after the NRU reactor in Chalk River, ON ceases isotope production in 2016. We are a huge step closer to being ready to enter supply stream for this city, this province, and this country.”


For more information about this topic please visit:


For more information about ACSI products please contact:

or call:



Share This Post

To bookmark this page, press the Ctrl (PCs) or Command (Macs) and D keys on your keyboard.

Email to a Friend:

Return to: Main Blog